Login or sign up
For business

Ayala pharmaceuticals

4.1· 9 reviews
Average ratingGreat
4.1/ 5

Based on 9 reviews

544%
422%
333%
20%
10%
Ask AI

What reviewers say about Ayala pharmaceuticals

Based on 9 reviews on Trustburn · updated 56 days ago

Most reviewers describe Ayala Pharmaceuticals in strongly positive terms, frequently praising the quality of its products, the knowledge and professionalism of its staff, and the ease and reliability of its service, with the majority of ratings being four or five stars.
What does Ayala pharmaceuticals do?

Ayala Pharmaceuticals is a clinical-stage oncology company that develops small molecule therapeutics for rare and aggressive cancers, primarily in genetically defined patient populations. It focuses on identifying tumorigenic drivers using a bioinformatics platform and next-generation sequencing to deliver targeted therapies, with product candidates AL101 and AL02 targeting the Notch pathway for tumors such as Adenoid Cystic Carcinoma, Triple Negative Breast Cancer, and T-cell Acute Lymphoblastic Leukemia.

What are the most common complaints about Ayala pharmaceuticals?

Based on the available reviews, no common complaints stand out; the only brief comment offering a mild critique noted a decent range of medications, with all other reviews being neutral to highly positive.

AI-generated from reviews on this page. Verify anything important with the company directly.

Jacqueline Trovato
Reviews 1

The service provided by this company is exceptional. I was impressed with the professionalism and expertise of the staff. They were able to answer all of my questions and provided helpful recommendations. I highly recommend Ayala Pharmaceuticals for all your pharmaceutical needs.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Ayala pharmaceuticals

Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. Ayala’s approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations. The company has two product candidates under development, AL101 and AL02, targeting the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat a variety of tumors including Adenoid Cystic Carcinoma, Triple Negative Breast Cancer, T-cell Acute Lymphoblastic Leukemia, Desmoid Tumors and Multiple Myeloma (in collaboration with Novartis).

Address
1313 north market street
Categories
Pharmaceuticals